{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:26:00Z","timestamp":1787729160701,"version":"build-2784847793"},"reference-count":65,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":299,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2015M3C9A4053391"],"award-info":[{"award-number":["2015M3C9A4053391"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019M3C9A6089879"],"award-info":[{"award-number":["2019M3C9A6089879"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1C1C2004318"],"award-info":[{"award-number":["2021R1C1C2004318"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.csbj.2021.10.032","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T20:55:55Z","timestamp":1635454555000},"page":"5920-5930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Gut microbiome signatures distinguish type 2 diabetes mellitus from non-alcoholic fatty liver disease"],"prefix":"10.34133","volume":"19","author":[{"given":"Jiyeon","family":"Si","sequence":"first","affiliation":[{"name":"Medical Science Research Institute, School of Medicine, Sungkyunkwan University (SKKU), Suwon 16419, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giljae","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Environmental Health Sciences, Graduate School of Public Health, Seoul National University, Seoul 08826, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Ju","family":"You","sequence":"additional","affiliation":[{"name":"Department of Environmental Health Sciences, Graduate School of Public Health, Seoul National University, Seoul 08826, Republic of Korea"},{"name":"Institute of Health and Environment, Seoul National University, Seoul 08826, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sae Kyung","family":"Joo","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul 07061, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Hyeon","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul 07061, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bon Jeong","family":"Ku","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon 35015, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seoyeon","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Environmental Health Sciences, Graduate School of Public Health, Seoul National University, Seoul 08826, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul 07061, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GwangPyo","family":"Ko","sequence":"additional","affiliation":[{"name":"Department of Environmental Health Sciences, Graduate School of Public Health, Seoul National University, Seoul 08826, Republic of Korea"},{"name":"Center for Human and Environmental Microbiome, Institute of Health and Environment, Seoul National University, Seoul 08826, Republic of Korea"},{"name":"KoBioLabs, Inc., Seoul 08826, Republic of Korea"},{"name":"Bio-MAX\/N-Bio, Seoul National University, Seoul 08826, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2021,11,9]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","article-title":"Noninvasive biomarkers in NAFLD and NASH \u2014 current progress and future promise","volume":"15","author":"Wong V.-S.","year":"2018","unstructured":"Wong V.-S., Adams L.A., de L\u00e9dinghen V., Wong G.-H. and Sookoian S.: Noninvasive biomarkers in NAFLD and NASH \u2014 current progress and future promise. Nature Rev Gastroenterol Hepatol 2018; 15: 461.","journal-title":"Nature Rev Gastroenterol Hepatol"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.06.021"},{"key":"e_1_3_5_4_2","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/ajg.2009.67","article-title":"NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study","volume":"104","author":"Adams L.A.","year":"2009","unstructured":"Adams L.A., Waters O.R., Knuiman M.W., Elliott R.R. and Olynyk J.K.: NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Am J Gastroenterol 2009; 104: 861.","journal-title":"Am J Gastroenterol"},{"key":"e_1_3_5_5_2","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/liv.12200","article-title":"Non-alcoholic fatty liver disease independently predicts prediabetes during a 7-year prospective follow-up","volume":"33","author":"Zelber-Sagi S.","year":"2013","unstructured":"Zelber-Sagi S., Lotan R., Shibolet O., Webb M., Buch A., Nitzan-Kaluski D. et al: Non-alcoholic fatty liver disease independently predicts prediabetes during a 7-year prospective follow-up. Liver Int 2013; 33: 1406.","journal-title":"Liver Int"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-021-00507-z"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature11450"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2017.04.001"},{"key":"e_1_3_5_9_2","article-title":"Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD","volume":"11","author":"Lee G.","year":"2020","unstructured":"Lee G., You H.J., Bajaj J.S., Joo S.K., Yu J., Park S. et al: Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD. Nat Commun 2020; 11.","journal-title":"Nat Commun"},{"key":"e_1_3_5_10_2","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/jgh.14056","article-title":"Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease","volume":"33","author":"Koo B.K.","year":"2018","unstructured":"Koo B.K., Joo S.K., Kim D., Bae J.M., Park J.H., Kim J.H. et al: Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2018; 33: 1277.","journal-title":"J Gastroenterol Hepatol"},{"key":"e_1_3_5_11_2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jhep.2016.08.019","article-title":"Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis","volume":"66","author":"Koo B.K.","year":"2017","unstructured":"Koo B.K., Kim D., Joo S.K., Kim J.H., Chang M.S., Kim B.G. et al: Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis. J Hepatol 2017; 66: 123.","journal-title":"J Hepatol"},{"key":"e_1_3_5_12_2","doi-asserted-by":"crossref","unstructured":"Diagnosis and classification of diabetes mellitus. Diabetes Care 2013;36:S67 LP-S74. https:\/\/doi.org\/10.2337\/dc13-S067.","DOI":"10.2337\/dc13-S067"},{"key":"e_1_3_5_13_2","doi-asserted-by":"crossref","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni G.","year":"2006","unstructured":"Bedogni G., Bellentani S., Miglioli L., Masutti F., Passalacqua M., Castiglione A. et al: The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006; 6.","journal-title":"BMC Gastroenterol"},{"key":"e_1_3_5_14_2","doi-asserted-by":"crossref","first-page":"1888673","DOI":"10.1080\/19490976.2021.1888673","article-title":"Links between gut microbiome composition and fatty liver disease in a large population sample","volume":"13","author":"Ruuskanen M.O.","year":"2021","unstructured":"Ruuskanen M.O., \u00c5berg F., M\u00e4nnist\u00f6 V., Havulinna A.S., M\u00e9ric G., Liu Y. et al: Links between gut microbiome composition and fatty liver disease in a large population sample. Gut Microbes 2021; 13: 1888673.","journal-title":"Gut Microbes"},{"key":"e_1_3_5_15_2","doi-asserted-by":"crossref","unstructured":"Brunt EM Janney CG di Bisceglie AM Neuschwander-Tetri BA Bacon BR. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Official Journal of the American College of Gastroenterology | ACG 1999;94.","DOI":"10.1111\/j.1572-0241.1999.01377.x"},{"key":"e_1_3_5_16_2","doi-asserted-by":"crossref","unstructured":"Brunt EM Kleiner DE Wilson LA Belt P Neuschwander-Tetri BA (CRN) for the NCRN. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology 2011;53:810\u201320. doi: 10.1002\/hep.24127.","DOI":"10.1002\/hep.24127"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20701"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3869"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1375\/twin.9.6.844"},{"key":"e_1_3_5_20_2","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.annepidem.2016.03.003","article-title":"It\u2019s all relative: analyzing microbiome data as compositions","volume":"26","author":"Gloor G.B.","year":"2016","unstructured":"Gloor G.B., Wu J.R., Pawlowsky-Glahn V. and Egozcue J.J.: It\u2019s all relative: analyzing microbiome data as compositions. Ann Epidemiol 2016; 26: 322.","journal-title":"Ann Epidemiol"},{"key":"e_1_3_5_21_2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.chemolab.2015.02.019","article-title":"zCompositions \u2014 R package for multivariate imputation of left-censored data under a compositional approach","volume":"143","author":"Palarea-Albaladejo J.","year":"2015","unstructured":"Palarea-Albaladejo J. and Mart\u00edn-Fern\u00e1ndez J.A.: zCompositions \u2014 R package for multivariate imputation of left-censored data under a compositional approach. Chemometrics and Intelligent Laboratory Systems 2015; 143: 85.","journal-title":"Chemometrics and Intelligent Laboratory Systems"},{"key":"e_1_3_5_22_2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.apsoil.2019.04.026","article-title":"Variations in soil and plant-microbiome composition with different quality irrigation waters and biochar supplementation","volume":"142","author":"Cui E.","year":"2019","unstructured":"Cui E., Fan X., Li Z., Liu Y., Neal A.L., Hu C. et al: Variations in soil and plant-microbiome composition with different quality irrigation waters and biochar supplementation. Appl Soil Ecol 2019; 142: 99.","journal-title":"Appl Soil Ecol"},{"key":"e_1_3_5_23_2","doi-asserted-by":"crossref","unstructured":"Mallick H Rahnavard A McIver LJ Ma S Zhang Y Nguyen LH et al. Multivariable association discovery in population-scale meta-omics Studies. BioRxiv 2021:2021.01.20.427420. doi: 10.1101\/2021.01.20.427420.","DOI":"10.1101\/2021.01.20.427420"},{"key":"e_1_3_5_24_2","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1126\/science.aad3503","article-title":"Population-level analysis of gut microbiome variation","volume":"352","author":"Falony G.","year":"2016","unstructured":"Falony G., Joossens M., Vieira-Silva S., Wang J., Darzi Y., Faust K. et al: Population-level analysis of gut microbiome variation. Science (New York, NY) 2016; 352: 560.","journal-title":"Science (New York, NY)"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1654-1103.2003.tb02228.x"},{"key":"e_1_3_5_26_2","unstructured":"Team RC. R: a language and environment for statistical computing. R Foundation for Statistical Computing 2019."},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061217"},{"key":"e_1_3_5_28_2","unstructured":"Barnier J. pairwiseAdonis: Pairwise multilevel comparison using adonis. R package version 0.4 2020."},{"key":"e_1_3_5_29_2","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1139\/cjm-2015-0821","article-title":"Compositional analysis: a valid approach to analyze microbiome high-throughput sequencing data","volume":"62","author":"Gloor G.B.","year":"2016","unstructured":"Gloor G.B. and Reid G.: Compositional analysis: a valid approach to analyze microbiome high-throughput sequencing data. Can J Microbiol 2016; 62: 692.","journal-title":"Can J Microbiol"},{"key":"e_1_3_5_30_2","unstructured":"Morgan M. DirichletMultinomial: dirichlet-multinomial mixture model machine learning for microbiome data. R package version 1.26.0. 2019."},{"key":"e_1_3_5_31_2","unstructured":"Fife D. A Biostatisticians toolbox for various activities including plotting data cleanup and data analysis. R package version 1.1. 2017."},{"key":"e_1_3_5_32_2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.5351\/CSAM.2015.22.6.665","article-title":"ppcor: an R Package for a fast calculation to semi-partial correlation coefficients","volume":"22","author":"Kim S.","year":"2015","unstructured":"Kim S.: ppcor: an R Package for a fast calculation to semi-partial correlation coefficients. Commun Statistical Appl Methods 2015; 22: 665.","journal-title":"Commun Statistical Appl Methods"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030126"},{"key":"e_1_3_5_34_2","doi-asserted-by":"crossref","unstructured":"Fuchs G Boll M Heider J. Microbial degradation of aromatic compounds \u2014 from one strategy to four. Nature Reviews Microbiology 2011 9:11 2011;9:803\u201316. doi: 10.1038\/nrmicro2652.","DOI":"10.1038\/nrmicro2652"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature15766"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature09944"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature13178"},{"key":"e_1_3_5_38_2","doi-asserted-by":"crossref","unstructured":"Wu GD Chen J Hoffmann C Bittinger K Chen Y-Y Keilbaugh SA et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011;334:105 LP \u2013 108. doi: 10.1126\/science.1208344.","DOI":"10.1126\/science.1208344"},{"key":"e_1_3_5_39_2","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/jgh.12665","article-title":"A single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)","volume":"29","author":"Otgonsuren M.","year":"2014","unstructured":"Otgonsuren M., Estep M.J., Hossain N., Younossi E., Frost S., Henry L. et al: A single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). J Gastroenterol Hepatol 2014; 29: 2006.","journal-title":"J Gastroenterol Hepatol"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1499-3872(17)60019-5"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26093"},{"key":"e_1_3_5_42_2","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.cmet.2020.06.005","article-title":"A universal gut-microbiome-derived signature predicts cirrhosis","volume":"32","author":"Oh T.G.","year":"2020","unstructured":"Oh T.G., Kim S.M., Caussy C., Fu T., Guo J., Bassirian S. et al: A universal gut-microbiome-derived signature predicts cirrhosis. Cell Metab 2020; 32: 878.","journal-title":"Cell Metab"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30908"},{"key":"e_1_3_5_44_2","article-title":"Altered fecal microbiota correlates with liver biochemistry in nonobese patients with non-alcoholic fatty liver disease","volume":"6","author":"Wang B.","year":"2016","unstructured":"Wang B., Jiang X., Cao M., Ge J., Bao Q., Tang L. et al: Altered fecal microbiota correlates with liver biochemistry in nonobese patients with non-alcoholic fatty liver disease. Sci Rep 2016; 6.","journal-title":"Sci Rep"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009085"},{"key":"e_1_3_5_46_2","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.aohep.2019.06.020","article-title":"Characteristics of intestinal bacteria with fatty liver diseases and cirrhosis","volume":"18","author":"Guohong-Liu","year":"2019","unstructured":"Guohong-Liu , Qingxi-Zhao and Hongyun-Wei : Characteristics of intestinal bacteria with fatty liver diseases and cirrhosis. Ann Hepatol 2019; 18: 796.","journal-title":"Ann Hepatol"},{"key":"e_1_3_5_47_2","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-021-00856-4","article-title":"Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India","volume":"13","author":"Alvarez-Silva C.","year":"2021","unstructured":"Alvarez-Silva C., Kashani A., Hansen T.H., Pinna N.K., Anjana R.M., Dutta A. et al: Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India. Genome Med 2021; 13.","journal-title":"Genome Med"},{"key":"e_1_3_5_48_2","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1038\/s41598-020-62224-3","article-title":"Implication of the gut microbiome composition of type 2 diabetic patients from northern China","volume":"10","author":"Li Q.","year":"2020","unstructured":"Li Q., Chang Y., Zhang K., Chen H., Tao S. and Zhang Z.: Implication of the gut microbiome composition of type 2 diabetic patients from northern China. Sci Rep 2020; 10: 5450.","journal-title":"Sci Rep"},{"key":"e_1_3_5_49_2","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3390\/nu13031013","article-title":"Characterization of gut microbiome in Korean patients with metabolic associated fatty liver disease","volume":"13","author":"Oh J.H.","year":"2021","unstructured":"Oh J.H., Lee J.H., Cho M.S., Kim H., Chun J., Lee J.H. et al: Characterization of gut microbiome in Korean patients with metabolic associated fatty liver disease. Nutrients 2021; 13: 1013.","journal-title":"Nutrients"},{"key":"e_1_3_5_50_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071108"},{"key":"e_1_3_5_51_2","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/01.ATV.20.3.830","article-title":"LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL","volume":"20","author":"Howard B.V.","year":"2000","unstructured":"Howard B.V., Robbins D.C., Sievers M.L., Lee E.T., Rhoades D., Devereux R.B. et al: LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL. Arterioscler Thromb Vasc Biol 2000; 20: 830.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"e_1_3_5_52_2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.atherosclerosis.2015.05.002","article-title":"Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease","volume":"241","author":"Chen Y.","year":"2015","unstructured":"Chen Y., Xu M., Wang T., Sun J., Sun W., Xu B. et al: Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease. Atherosclerosis 2015; 241: 145.","journal-title":"Atherosclerosis"},{"key":"e_1_3_5_53_2","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3748\/wjg.v19.i8.1219","article-title":"NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients","volume":"19","author":"Treeprasertsuk S.","year":"2013","unstructured":"Treeprasertsuk S., Bj\u00f6rnsson E., Enders F., Suwanwalaikorn S. and Lindor K.D.: NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients. World J Gastroenterol 2013; 19: 1219.","journal-title":"World J Gastroenterol"},{"key":"e_1_3_5_54_2","doi-asserted-by":"crossref","first-page":"110","DOI":"10.21215\/kjfp.2020.10.2.110","article-title":"The association between non-alcoholic fatty liver disease fibrosis score and serum low density lipoprotein-cholesterol levels in adults with non-alcoholic fatty liver disease","volume":"10","author":"Park S.B.","year":"2020","unstructured":"Park S.B., Choi H.J., Doo S.H., Jung D., Shim Y.N. and Oh H.J.: The association between non-alcoholic fatty liver disease fibrosis score and serum low density lipoprotein-cholesterol levels in adults with non-alcoholic fatty liver disease. Korean J Family Practice 2020; 10: 110.","journal-title":"Korean J Family Practice"},{"key":"e_1_3_5_55_2","doi-asserted-by":"crossref","unstructured":"Klimentidis YC Arora A Newell M Zhou J Ordovas JM Renquist BJ et al. Phenotypic and genetic characterization of lower LDL cholesterol and increased type 2 diabetes risk in the UK biobank. Diabetes 2020;69:2194 LP \u2013 2205.","DOI":"10.2337\/db19-1134"},{"key":"e_1_3_5_56_2","doi-asserted-by":"crossref","unstructured":"Dubinsky V Reshef L Rabinowitz K Yadgar K Godny L Zonensain K et al. Dysbiosis in Metabolic Genes of the Gut Microbiomes of Patients with an Ileo-anal Pouch Resembles That Observed in Crohn\u2019s Disease. MSystems 2021;6. doi: 10.1128\/MSYSTEMS.00984-20.","DOI":"10.1128\/msystems.00984-20"},{"key":"e_1_3_5_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31056"},{"key":"e_1_3_5_58_2","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.cmet.2019.11.006","article-title":"Fatty liver disease caused by high-alcohol-producing Klebsiella pneumoniae","volume":"30","author":"Yuan J.","year":"2019","unstructured":"Yuan J., Chen C., Cui J., Lu J., Yan C., Wei X. et al: Fatty liver disease caused by high-alcohol-producing Klebsiella pneumoniae. Cell Metab 2019; 30: 1172.","journal-title":"Cell Metab"},{"key":"e_1_3_5_59_2","doi-asserted-by":"crossref","unstructured":"Maier L Pruteanu M Kuhn M Zeller G Telzerow A Anderson EE et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 2018 555:7698 2018;555:623\u20138. doi: 10.1038\/nature25979.","DOI":"10.1038\/nature25979"},{"key":"e_1_3_5_60_2","doi-asserted-by":"crossref","unstructured":"Vich Vila A Collij V Sanna S Sinha T Imhann F Bourgonje AR et al. Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nature Communications 2020 11:1 2020;11:1\u201311. doi: 10.1038\/s41467-019-14177-z.","DOI":"10.1038\/s41467-019-14177-z"},{"key":"e_1_3_5_61_2","doi-asserted-by":"crossref","unstructured":"Wu H Esteve E Tremaroli V Khan MT Caesar R Manner\u00e5s-Holm L et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes contributing to the therapeutic effects of the drug. Nature Medicine 2017 23:7 2017;23:850\u20138. doi: 10.1038\/nm.4345.","DOI":"10.1038\/nm.4345"},{"key":"e_1_3_5_62_2","doi-asserted-by":"crossref","unstructured":"Singh RK Chang H-W Yan D Lee KM Ucmak D Wong K et al. Influence of diet on the gut microbiome and implications for human health. J Transl Med 2017 15:1 2017;15:1\u201317. doi: 10.1186\/S12967-017-1175-Y.","DOI":"10.1186\/s12967-017-1175-y"},{"key":"e_1_3_5_63_2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.21037\/hbsn.2018.12.05","article-title":"Nonalcoholic fatty liver disease (NAFLD) prevention: role of Mediterranean diet and physical activity","volume":"8","author":"Trovato F.M.","year":"2019","unstructured":"Trovato F.M., Castrogiovanni P., Malatino L. and Musumeci G.: Nonalcoholic fatty liver disease (NAFLD) prevention: role of Mediterranean diet and physical activity. Hepatobiliary Surgery and Nutrition 2019; 8: 167.","journal-title":"Hepatobiliary Surgery and Nutrition"},{"key":"e_1_3_5_64_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature24460"},{"key":"e_1_3_5_65_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-018-0337-x"},{"key":"e_1_3_5_66_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-019-0483-9"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037021004542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037021004542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2021.10.032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T12:51:41Z","timestamp":1779022301000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2021.10.032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":65,"alternative-id":["10.1016\/j.csbj.2021.10.032"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2021.10.032","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbiome signatures distinguish type 2 diabetes mellitus from non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2021.10.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}